Navigation Links
Cord Blood Stem Cells Stored at No Cost to Families with an Identified Medical Need Provide Therapeutic Options
Date:2/14/2013

TUCSON, Ariz., Feb. 14, 2013 /PRNewswire/ -- Thanks to the Newborn Possibilities Program® by Cord Blood Registry® (CBR®), families facing serious medical conditions with few options may have access to family cord blood stem cell banking services at no cost. This program enables access to genetically related newborn stem cells for future treatment. A group of families who participated in the Tucson Medical Center pilot of the Newborn Possibilities Program have participated in clinical trials using their own stem cells. One Tucson mom, Jessica Schaefer , had a difficult pregnancy with complications that qualified her for this program when she delivered her son, Logan. Logan's cord blood stem cells were processed and stored in CBR's state-of-the-art stem cell processing and storage facility at no cost and provided a therapeutic option for him.

(Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO)

"I am blown away that this program was available to me when I delivered Logan," says Schaefer. "I am so grateful to CBR for the chance to have my son participate in the Medical College of Georgia's clinical trial for cerebral palsy. We feel blessed to have the unique opportunity to possibly help Logan lead a happier life, while also helping to advance the science of stem cell therapies."

The Newborn Possibilities Program is a corporate initiative from Cord Blood Registry designed to ensure that families with an identified medical need and babies born after high-risk deliveries have a free option to save cord blood stem cells in the event they may be used in future treatment and potentially provide access to clinical trials. Nearly 3,000 physicians have collected units for the Newborn Possibilities Program and CBR has stored nearly 5,000 units under the program since its inception.

Stem Cell Collection Pilot Paves Path to Clinical Trial Enrollment
"We created the Newborn Possibilities Program as a catalyst for medical researchers to advance clinical trials involving newborn stem cells," says Geoffrey Crouse , chief executive officer of CBR.  "At the same time, we help identify families with a diagnosed condition who might directly benefit from family banking through a transplant."

Cherie Lennex has also enrolled her son, Nathan, in the cord blood stem cell trial for cerebral palsy in Georgia. She had learned about her options for saving cord blood, but could not fit private storage in her budget at the time. Her pregnancy was routine, but Nathan came early, qualifying her for the Newborn Possibilities Program Tucson Medical Center pilot.

"When representatives from the program called for a routine follow-up to check on Nathan's development, we confirmed he was missing milestones and might be at risk for developing cerebral palsy," noted Lennex. "Nathan was my first child and I hadn't really considered that something might be wrong with his development. Once he was diagnosed with cerebral palsy and we were informed of the study in Georgia, it became immensely clear just how fortunate we are to have his stem cells stored. We are very grateful."

In less than two years under the Newborn Possibilities Program Tucson Medical Center pilot, cord blood stem cells were collected and stored at no cost from more than 1,100 babies who demonstrated signs of potential neurologic damage based upon predetermined criteria. Following the cord blood collection, CBR program managers contact the families on a regular basis to track the children's medical and developmental status. Of those who have been evaluated to date, early assessments helped CBR  identify seven children within one year of their birth, with conditions where stem cells are being investigated as potential treatments. Three of those children have enrolled in clinical trials and more than 60 children have been identified at this early stage as being at risk for developmental delays by 24 months of age, which can be an indicator of neurological damage. 

Please visit www.cordblood.com to learn more about the Newborn Possibilities Program or www.cordbankingbasics.com for an interactive experience that helps expectant parents and others make informed choices about saving cord blood stem cells.

About CBR

Cord Blood Registry® (CBR®) is the world's largest and most experienced newborn stem cell bank.  The company has consistently led the industry in technical innovations and supporting clinical trials. It safeguards more than 400,000 cord blood collections for individuals and their families. CBR was the first family bank accredited by AABB and the company's quality standards have been recognized through ISO 9001:2008 certification—the global business standard for quality. CBR has also released more client cord blood units for specific therapeutic use than any other family cord blood bank. Our research and development efforts are focused on helping the world's leading clinical researchers advance regenerative medical therapies. For more information, visit www.cordblood.com.


'/>"/>
SOURCE Cord Blood Registry (CBR)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
2. In Preventing Diabetes-Related Heart Disease, Blood Pressure and Cholesterol Targets are Higher Priorities than Blood Sugar
3. HemaTerra Announces New Quality Control Product For Blood Centers
4. $4 Co-pay on Kroger Premium Blood Glucose Test Strips
5. Lower Copayments and Use of Mail-Order Pharmacy may Reduce Disparities in Adherence to Blood-Pressure Medication
6. Research Published in European Journal of Pharmacology Shows that Star Scientifics Anatabine Suppresses Brain Inflammation in Animal Model of Alzheimers Disease and in Blood
7. The Princess Margaret BMT Program Chooses Remedy Informatics Blood and Marrow Transplant & Cell Therapy Solutions to Power their fight Against Cancer
8. Amarantus Biosciences and RBCC Outline Terms for NuroPro Parkinsons Blood Test Joint Venture
9. Phase 3 Results Show Canagliflozin as Add-On Therapy to Metformin and Pioglitazone Significantly Lowers Blood Sugar Levels in Adult Patients with Type 2 Diabetes
10. DioGenix and Fast Forward Collaborate to Develop Blood-Based Molecular Diagnostic for Multiple Sclerosis
11. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... An August 3rd article on Reuters covers ... of a report in JAMA (the Journal of the American Medical Association). The study found ... to achieve BMIs under 30, when compared to patients with lower BMIs. At present, weight ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
(Date:8/16/2017)... Brentwood, TN (PRWEB) , ... August 16, 2017 ... ... market-leading dermatology practice partnerships through affiliations and de novo development, today announced ... practice. , Cumberland Skin Surgery and Dermatology, with offices in both Hermitage ...
(Date:8/16/2017)... ... 16, 2017 , ... Paul Vitenas, MD, FACS , is honored to ... annual list identifies the nation’s top physicians, in a variety of specialties. This marks ... top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
Breaking Medicine News(10 mins):